Drug Therapy of Tardive Dyskinesia
- 3 February 1977
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 296 (5) , 257-260
- https://doi.org/10.1056/nejm197702032960506
Abstract
Drug-induced tardive dyskinesia represents a major side effect limiting long-term use of antipsychotic drugs and responds poorly to treatment. The drugs most frequently associated with this syndrome are the phenothiazines and haloperidol. Spontaneous cases are infrequent as compared to drug-related ones. Although the exact frequency is difficult to assess, spontaneous tardive dyskinesia has been estimated to occur in 3 to 6 per cent of a mixed population of psychiatric patients1 and in up to 40 per cent of elderly, chronically institutionalized patients.2 The disorder thus appears most frequently in the elderly and in patients treated with high doses of antipsychotic . . .This publication has 23 references indexed in Scilit:
- Spontaneous Oral DyskinesiaArchives of Neurology, 1974
- CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974
- Antischizophrenic Drugs and Brain Cholinergic ReceptorsArchives of General Psychiatry, 1974
- Neurologic Syndromes Associated with Antipsychotic-Drug UseNew England Journal of Medicine, 1973
- Persistent DyskinesiaThe British Journal of Psychiatry, 1973
- The Pharmacology of Tardive DyskinesiasAmerican Journal of Psychiatry, 1973
- Therapeutic Approaches to Tardive DyskinesiaArchives of General Psychiatry, 1972
- Treatment of Tardive DyskinesiaArchives of General Psychiatry, 1972
- Das klinische Wirkungsbild von Clozapin: (Untersuchung mit dem AMP-System)Pharmacopsychiatry, 1971
- TREATMENT OF DRUG-INDUCED DYSKINESIASThe Lancet, 1970